What does Ally Bridge Group invest in?
Ally Bridge Group invests most often at Series A and Series B (50% of the rounds on record), in sectors such as Connected Health, Healthier Living and Healthtech.

Hong Kong SAR China · Investor
Last cheque observed Jul 2026; 24 cheques on record.
Private equityDeploying now
Follow Ally Bridge Group and see its new cheques in your feed. Start following
3 cheques in the last 12 months
Mostly Series A and Series B: 50% of its rounds
Sole investor in 5 rounds, median $14M
Ally Bridge Group is a global healthcare investment management firm.From their own website
Every round we can evidence, newest first24 appearances
3 rounds
2 rounds
2 rounds
2 rounds
3 rounds
1 round
5 rounds
5 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
We also hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
9 private funds, $1.3B in gross assets · filed Mar 2024
Private equity 6Hedge 3
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Ally Bridge Group. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Ally Bridge Group put money into.
Ally Bridge Group invests most often at Series A and Series B (50% of the rounds on record), in sectors such as Connected Health, Healthier Living and Healthtech.
24 investments on record, 3 of them in the last 12 months, and it led 6. The most recent was in Jul 2026.
Its most recent investments on record: AdvanCell (Series D, Jul 2026), Imperative Care, Inc. (Undisclosed round, Mar 2026) and Biobeat Technologies, Ltd. (Series B, Jan 2026).
The median round it joins is $100M.
Yes: it led 6 of its 24 investments on record (25%).
Most of the companies it backs are in the United States (65%) and China (17%).
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often Bain Capital Life Sciences (3 rounds together), Catalio Capital Management (3 rounds together) and Elevage Medical Technologies (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it